Cardiac mitochondrial function and tissue remodelling are improved by a non-antihypertensive dose of enalapril in spontaneously hypertensive rats

References

• Nadar SK, Tayebjee MH, Messerli F, Lip GY. Target organ damage in hypertension: pathophysiology and implications for drug therapy. Curr Pharm Des 2006; 12: 1581–1592
   PubMed Web of Science ®Google Scholar
• Mensah GA, Croft JB, Giles WH. The heart, kidney, and brain as target organs in hypertension. Cardiol Clin 2002; 20: 225–247
   PubMedGoogle Scholar
• Dahlof B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan intervention for endpoint reduction in hypertension. Hypertension 1998; 32: 989–997
   PubMed Web of Science ®Google Scholar
• HOPE, Study, Investigators. Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253–259.
   PubMed Web of Science ®Google Scholar
• Rodby RA, Firth LM, Lewis EJ. An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group. Diabetes Care 1996; 19: 1051–1061
   PubMed Web of Science ®Google Scholar
• Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 2004; 44: 248–252
   PubMed Web of Science ®Google Scholar
• Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005; 38: 1278–1295
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007; 100: 460–473
   PubMed Web of Science ®Google Scholar
• Budnikov E, Postnov A, Doroshchuk AD, Afanasjeva GV, Postnov Iu V. Decreased ATP-synthesis ability of liver mitochondria in spontaneously hypertensive rats (SHR): role of calcium overload of the mitochondria]. Kardiologiia 2002; 42: 47–50
   Google Scholar
• Lakomkin VL, Konovalova GG, Kalenikova EI, Zabbarova IV, Tsyplenkova VG, Tikhaze AK, Lankin VZ, Ruuge EK, Kapel'ko VI. Effect of ubiquinone on contractile function and antioxidant status of the myocardium in spontaneously hypertensive rats]. Kardiologiia 2006; 46: 54–62
   Google Scholar
• Ito H, Torii M, Suzuki T. Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin Exp Hypertens 1995; 17: 803–816
   PubMed Web of Science ®Google Scholar
• Seccia TM, Atlante A, Vulpis V, Marra E, Passarella S, Pirrelli A. Abnormal transport of inorganic phosphate in left ventricular mitochondria from spontaneously hypertensive rats. Cardiologia 1999; 44: 719–725
   PubMedGoogle Scholar
• Chen L, Tian X, Song L. Biochemical and biophysical characteristics of mitochondria in the hypertrophic hearts from hypertensive rats. Chin Med J (Engl) 1995; 108: 361–366
   PubMed Web of Science ®Google Scholar
• Thomas DD, Liu X, Kantrow SP, Lancaster JR, Jr. The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci USA 2001; 98: 355–360
   PubMed Web of Science ®Google Scholar
• Brookes P, Darley-Usmar VM. Hypothesis: the mitochondrial NO signaling pathway, and the transduction of nitrosative to oxidative cell signals: an alternative function for cytochrome C oxidase. Free Radic Biol Med 2002; 32: 370–374
   PubMed Web of Science ®Google Scholar
• Brookes PS, Salinas EP, Darley-Usmar K, Eiserich JP, Freeman BA, Darley-Usmar VM, Anderson PG. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 2000; 275: 20474–20479
   PubMed Web of Science ®Google Scholar
• de Cavanagh EM, Toblli JE, Ferder L, Piotrkowski B, Stella I, Inserra F. Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1616–R1625
   PubMed Web of Science ®Google Scholar
• Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 2008; 102: 488–496
   PubMed Web of Science ®Google Scholar
• Nakagami H, Takemoto M, Liao JK. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 2003; 35: 851–859
   PubMed Web of Science ®Google Scholar
• Pagano PJ, Chanock SJ, Siwik DA, Colucci WS, Clark JK. Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 1998; 32: 331–337
   PubMed Web of Science ®Google Scholar
• Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 1998; 274: C214–C220
   PubMed Web of Science ®Google Scholar
• Hennington BS, Zhang H, Miller MT, Granger JP, Reckelhoff JF. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension 1998; 31: 283–288
   PubMed Web of Science ®Google Scholar
• Olson S, Oeckler R, Li X, Du L, Traganos F, Zhao X, Burke-Wolin T. Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor. Am J Physiol Lung Cell Mol Physiol 2004; 287: L559–L568
   Web of Science ®Google Scholar
• Thorup C, Kornfeld M, Winaver JM, Goligorsky MS, Moore LC. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflugers Arch 1998; 435: 432–434
   PubMed Web of Science ®Google Scholar
• Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 2005; 45: 438–444
   PubMed Web of Science ®Google Scholar
• de Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L, Fraga CG. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. Faseb J 2003; 17: 1096–1098
   PubMed Web of Science ®Google Scholar
• Junquiera LC, Junqueira LC, Brentani RR. A simple and sensitive method for the quantitative estimation of collagen. Anal Biochem 1979; 94: 96–99
   PubMed Web of Science ®Google Scholar
• Rickwood D, Wilson MT, Darley-Usmar VM. Isolation and characteristics of intact mitochondria. In: Darley-Usmar V, Rickwood D, Wilson MT. Mitochondria: a practical approach. 1987; IRL Press, Washington, DC. p 1–16.
   Google Scholar
• Forstermann U, Gath I. Purification of isoforms of nitric oxide synthase. Methods Enzymol 1996; 268: 334–339
   Google Scholar
• Chemnitius JM, Manglitz T, Kloeppel M, Doenst T, Schwartz P, Kreuzer H, Zech R. Rapid preparation of subsarcolemmal and interfibrillar mitochondrial subpopulations from cardiac muscle. Int J Biochem 1993; 25: 589–596
   PubMedGoogle Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Shimokawa Ki K, Katayama M, Matsuda Y, Takahashi H, Hara I, Sato H, Kaneko S. Matrix metalloproteinase (MMP)-2 and MMP-9 activities in human seminal plasma. Mol Hum Reprod 2002; 8: 32–36
   PubMed Web of Science ®Google Scholar
• Mehanna AS, Dowling M. Liquid chromatographic determination of hippuric acid for the evaluation of ethacrynic acid as angiotensin converting enzyme inhibitor. J Pharm Biomed Anal 1999; 19: 967–973
   PubMed Web of Science ®Google Scholar
• King TE, Howard RL. Preparation and properties of soluble NADH dehydrogenases from cardiac muscle. Methods Enzymol 1967; 10: 275–294
   Google Scholar
• Capaldi RA, Marusich MF, Taanman JW. Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells. Methods Enzymol 1995; 260: 117–132
   PubMed Web of Science ®Google Scholar
• Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol 1984; 105: 93–104
   PubMed Web of Science ®Google Scholar
• Scaduto RC, Jr, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 1999; 76: 469–477
   PubMed Web of Science ®Google Scholar
• Jones OT, Hancock JT. Assays of plasma membrane NADPH oxidase. Methods Enzymol 1994; 233: 222–229
   Google Scholar
• Knowles RG, Salter M. Measurement of NOS activity by conversion of radiolabeled arginine to citrulline using ion-exchange separation. Methods Mol Biol 1998; 100: 67–73
   PubMedGoogle Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Mathur A, Hong Y, Kemp BK, Barrientos AA, Erusalimsky JD. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res 2000; 46: 126–138
   PubMed Web of Science ®Google Scholar
• Leary SC, Michaud D, Lyons CN, Hale TM, Bushfield TL, Adams MA, Moyes CD. Bioenergetic remodeling of heart during treatment of spontaneously hypertensive rats with enalapril. Am J Physiol Heart Circ Physiol 2002; 283: H540–H548
   Google Scholar
• Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 1997; 80: 15L–25L
   PubMed Web of Science ®Google Scholar
• Makino N, Sugano M, Ohtsuka S, Sawada S, Hata T. Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats. Cardiovasc Res 1999; 44: 543–548
   PubMed Web of Science ®Google Scholar
• Obata J, Nakamura T, Takano H, Naito A, Kimura H, Yoshida Y, Shimizu F, Guo DF, Inagami T. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000; 18: 1247–1255
   PubMed Web of Science ®Google Scholar
• Mancini A, Di Battista JA. Transcriptional regulation of matrix metalloprotease gene expression in health and disease. Front Biosci 2006; 11: 423–446
   PubMed Web of Science ®Google Scholar
• Pieske B. Reverse remodeling in heart failure—fact or fiction?. Eur Heart J Suppl 2004; 6: D66–D78
   Google Scholar
• Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta P, Columbaro M, Volpin D, Bressan GM, Bernardi P, Bonaldo P. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 2003; 35: 367–371
   PubMed Web of Science ®Google Scholar
• Wu D, Chen X, Guo D, Hong Q, Fu B, Ding R, Yu L, Hou K, Feng Z, Zhang X, Wang J. Knockdown of fibronectin induces mitochondria-dependent apoptosis in rat mesangial cells. J Am Soc Nephrol 2005; 16: 646–657
   Google Scholar
• van Waveren C, Sun Y, Cheung HS, Moraes CT. Oxidative phosphorylation dysfunction modulates expression of extracellular matrix—remodeling genes and invasion. Carcinogenesis 2006; 27: 409–418
   PubMed Web of Science ®Google Scholar
• Zhou HZ, Ma X, Gray MO, Zhu BQ, Nguyen AP, Baker AJ, Simonis U, Cecchini G, Lovett DH, Karliner JS. Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Biochem Biophys Res Commun 2007; 358: 189–195
   PubMed Web of Science ®Google Scholar
• Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328: 309–316
   PubMed Web of Science ®Google Scholar
• Riobo NA, Clementi E, Melani M, Boveris A, Cadenas E, Moncada S, Poderoso JJ. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem J 2001; 359: 139–145
   PubMed Web of Science ®Google Scholar
• Csonka C, Pataki T, Kovacs P, Muller SL, Schroeter ML, Tosaki A, Blasig IE. Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radic Biol Med 2000; 29: 612–619
   PubMed Web of Science ®Google Scholar
• Sainz J, Wangensteen R, Rodriguez Gomez I, Moreno JM, Chamorro V, Osuna A, Bueno P, Vargas F. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Am J Hypertens 2005; 18: 871–877
   Google Scholar
• Ranganathan AC, Nelson KK, Rodriguez AM, Kim KH, Tower GB, Rutter JL, Brinckerhoff CE, Huang TT, Epstein CJ, Jeffrey JJ, Melendez JA. Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. J Biol Chem 2001; 276: 14264–14270
   PubMed Web of Science ®Google Scholar
• Han D, Antunes F, Canali R, Rettori D, Cadenas E. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J Biol Chem 2003; 278: 5557–5563
   PubMed Web of Science ®Google Scholar
• Zhang X, Xie YW, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 1997; 95: 176–182
   PubMed Web of Science ®Google Scholar
• Demacq C, Metzger IF, Gerlach RF, Tanus-Santos JE. Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers. Clin Chim Acta 2008; 394: 72–76
   PubMed Web of Science ®Google Scholar
• De Gennaro Colonna V, Rossoni G, Rigamonti A, Bonomo S, Manfredi B, Berti F, Muller E. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur J Pharmacol 2002; 450: 61–66
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Honda T, Yoshida K, Nakano S, Ohno T, Tsubokou Y, Matsuoka H. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition. Atherosclerosis 2006; 187: 92–100
   PubMed Web of Science ®Google Scholar
• Rubbo H, Darley-Usmar V, Freeman BA. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 1996; 9: 809–820
   PubMed Web of Science ®Google Scholar
• Zhou XJ, Vaziri ND, Zhang J, Wang HW, Wang XQ. Association of renal injury with nitric oxide deficiency in aged SHR: prevention by hypertension control with AT1 blockade. Kidney Int 2002; 62: 914–921
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Liang K, Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 1999; 56: 1492–1498
   PubMed Web of Science ®Google Scholar
• Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2005; 102: 9056–9061
   PubMed Web of Science ®Google Scholar
• Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998; 273: 25804–25808
   PubMed Web of Science ®Google Scholar
• Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 1994; 266: H2568–H2572
   PubMed Web of Science ®Google Scholar